Abstract

To clarify the molecular mechanism for analog potency and selectivity, we investigated the ability of 1,25(OH) 2D 3 analogs to recruit coactivators to the vitamin D receptor (VDR) transcriptional complex. Using a modified version of the avidin–biotin complex DNA binding assay, we discovered that 20 S-analogs enhance the binding of specific coactivators to the transcriptional complex relative to natural hormone and that the enhanced binding occurs independently of vitamin D response element and cell type. With the exception of two of these coactivators, DRIP205 and DRIP240, all proteins were recruited to the transcriptional complex in a dose-dependent manner. While the results do not provide an explanation for tissue selectivity of 2-methylene-19-nor-(20 S)-1,25-dihydroxyvitamin D 3 (2MD), they provide evidence that in the presence of a full-length side chain, the 20 S configuration improves binding of specific proteins to the VDR transcriptional complex while modifications at carbon 2 do not.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.